474 related articles for article (PubMed ID: 16481328)
1. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A
J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328
[TBL] [Abstract][Full Text] [Related]
2. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity.
Fang J; Lu J; Holmgren A
J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598
[TBL] [Abstract][Full Text] [Related]
4. The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy.
Biaglow JE; Miller RA
Cancer Biol Ther; 2005 Jan; 4(1):6-13. PubMed ID: 15684606
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin reductase from Bacillus cereus exhibits distinct reduction and NADPH-binding properties.
Shoor M; Gudim I; Hersleth HP; Hammerstad M
FEBS Open Bio; 2021 Nov; 11(11):3019-3031. PubMed ID: 34492167
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase.
Zahedi Avval F; Holmgren A
J Biol Chem; 2009 Mar; 284(13):8233-40. PubMed ID: 19176520
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide.
Pannala VR; Dash RK
Free Radic Biol Med; 2015 Jan; 78():42-55. PubMed ID: 25451645
[TBL] [Abstract][Full Text] [Related]
8. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
Huang J; Xu J; Tian L; Zhong L
Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd).
Zahedi Avval F; Berndt C; Pramanik A; Holmgren A
Biochem Biophys Res Commun; 2009 Feb; 379(3):775-9. PubMed ID: 19121624
[TBL] [Abstract][Full Text] [Related]
10. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant.
Zhao R; Masayasu H; Holmgren A
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8579-84. PubMed ID: 12070343
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-dependent thioredoxin reduction and lipoamide system support in-vitro mammalian ribonucleotide reductase catalysis: a possible antioxidant redundancy.
Chatterji A; Sachin K; Sengupta R
Mol Biol Rep; 2022 Aug; 49(8):8179-8183. PubMed ID: 35655055
[TBL] [Abstract][Full Text] [Related]
12. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase.
Björnstedt M; Kumar S; Holmgren A
J Biol Chem; 1992 Apr; 267(12):8030-4. PubMed ID: 1569062
[TBL] [Abstract][Full Text] [Related]
13. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen.
Kumar S; Björnstedt M; Holmgren A
Eur J Biochem; 1992 Jul; 207(2):435-39. PubMed ID: 1321713
[TBL] [Abstract][Full Text] [Related]
14. Functional analyses of ancestral thioredoxins provide insights into their evolutionary history.
Napolitano S; Reber RJ; Rubini M; Glockshuber R
J Biol Chem; 2019 Sep; 294(38):14105-14118. PubMed ID: 31366732
[TBL] [Abstract][Full Text] [Related]
15. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
Montano SJ; Lu J; Gustafsson TN; Holmgren A
Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
[TBL] [Abstract][Full Text] [Related]
17. Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic.
Ren X; Zou L; Lu J; Holmgren A
Free Radic Biol Med; 2018 Nov; 127():238-247. PubMed ID: 29807162
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin reductase as a pharmacological target.
Bjørklund G; Zou L; Wang J; Chasapis CT; Peana M
Pharmacol Res; 2021 Dec; 174():105854. PubMed ID: 34455077
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin reductase-thioredoxin fusion enzyme from Mycobacterium leprae: comparison with the separately expressed thioredoxin reductase.
Wang PF; Marcinkeviciene J; Williams CH; Blanchard JS
Biochemistry; 1998 Nov; 37(46):16378-89. PubMed ID: 9819230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
